Amerise Biosciences Limited (BOM:531681)
India
· Delayed Price · Currency is INR 0.8600
-0.0200 (-2.27%)
At close: Apr 25, 2025
Amerise Biosciences Revenue
Amerise Biosciences had revenue of 358.00K INR in the twelve months ending December 31, 2024, up 17,800.00% year-over-year. In the fiscal year ending March 31, 2024, Amerise Biosciences had annual revenue of 359.00K with 307.95% growth.
Revenue (ttm)
358.00K
Revenue Growth
+17,800.00%
P/S Ratio
155.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
55.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 359.00K | 271.00K | 307.95% |
| Mar 31, 2023 | 88.00K | -95.69M | -99.91% |
| Mar 31, 2022 | 95.77M | 97.46M | -5,768.30% |
| Mar 31, 2021 | -1.69M | -1.70M | -29,618.54% |
| Mar 31, 2020 | 5.72K | -11.79M | -99.95% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,409.52B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |